OneSource supports second generic semaglutide approval in Canada EP News Bureau May 5, 2026 OneSource Specialty Pharma, a leading specialty pharmaceutical CDMO, announced that its partner Orbicular, along with its Canadian…
Strides, Orbicular sign pact to jointly develop a range of nasal sprays EP News Bureau May 3, 2023 The partnership will commercialise four nasal sprays with a combined global IQVIA market size in excess of $400 million
